Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 138

1.

A panel of protein markers for the early detection of lung cancer with bronchial brushing specimens.

Liu YZ, Jiang YY, Wang BS, Hao JJ, Shang L, Zhang TT, Cao J, Xu X, Zhan QM, Wang MR.

Cancer Cytopathol. 2014 Nov;122(11):833-41. doi: 10.1002/cncy.21461. Epub 2014 Jul 9.

2.

[Expression of EGFR, survivn and hnRNPA2/B1 in bronchial brushing cytology specimens and their significance in diagnosis of lung cancer].

Lu SS, Pan QJ, Zhao LL, Guo HQ, Zhang ZH, Cao J.

Zhonghua Zhong Liu Za Zhi. 2011 Aug;33(8):621-5. Chinese.

PMID:
22325225
3.

Prognostic significance of MCM7 expression in the bronchial brushings of patients with non-small cell lung cancer (NSCLC).

Liu YZ, Jiang YY, Hao JJ, Lu SS, Zhang TT, Shang L, Cao J, Song X, Wang BS, Cai Y, Zhan QM, Wang MR.

Lung Cancer. 2012 Jul;77(1):176-82. doi: 10.1016/j.lungcan.2012.03.001. Epub 2012 Mar 26.

PMID:
22456526
4.

Comparison of the expression levels of napsin A, thyroid transcription factor-1, and p63 in nonsmall cell lung cancer using cytocentrifuged bronchial brushings.

Aikawa E, Kawahara A, Hattori S, Yamaguchi T, Abe H, Taira T, Azuma K, Kage M.

Cancer Cytopathol. 2011 Oct 25;119(5):335-45. doi: 10.1002/cncy.20162. Epub 2011 Jun 29.

5.

[Application of protein markers in combination with ThinPrep bronchial brush cytology in classification of lung cancer subtypes].

Yang Y, Pan QJ, Teng MF, Li ZL, Zhao LL, Han NJ, Gao YN, Cao J.

Zhonghua Zhong Liu Za Zhi. 2008 Aug;30(8):616-9. Chinese.

PMID:
19102942
6.

Correlation between morphology and human telomerase gene amplification in bronchial brushing cells for the diagnosis of lung cancer.

Fan YB, Ye L, Wang TY, Wu GP.

Diagn Cytopathol. 2010 Jun;38(6):402-6. doi: 10.1002/dc.21235.

PMID:
19877284
7.

Expression and clinical significance of lung-specific X protein mRNA in bronchial brushing specimens from patients with or without lung cancer.

Lv M, Wu MZ, Zhao YJ, Yang DI, Wang EH, Wu GP.

Respirology. 2011 Oct;16(7):1076-80. doi: 10.1111/j.1440-1843.2011.02008.x.

PMID:
21651644
8.

A comparison of cytology and fluorescence in situ hybridization for the detection of lung cancer in bronchoscopic specimens.

Halling KC, Rickman OB, Kipp BR, Harwood AR, Doerr CH, Jett JR.

Chest. 2006 Sep;130(3):694-701.

PMID:
16963665
9.

A potential probe set of fluorescence in situ hybridization for detection of lung cancer in bronchial brushing specimens.

Liu YZ, Wang Z, Fang LL, Li L, Cao J, Xu X, Han YL, Cai Y, Wang LX, Wang MR.

J Cancer Res Clin Oncol. 2012 Sep;138(9):1541-9. doi: 10.1007/s00432-012-1232-0. Epub 2012 Apr 27.

PMID:
22538453
10.

Multi-gene analyses from waste brushing specimens for patients with peripheral lung cancer receiving EBUS-assisted bronchoscopy.

Tsai TH, Yang CY, Ho CC, Liao WY, Jan IS, Chen KY, Wang JY, Ruan SY, Yu CJ, Yang JC, Yang PC, Shih JY.

Lung Cancer. 2013 Dec;82(3):420-5. doi: 10.1016/j.lungcan.2013.10.005. Epub 2013 Oct 14.

PMID:
24183104
11.

[Value of ThinPrep bronchial brushing cytology in the diagnosis of lung cancers].

Cao J, Pan QJ, Li ZL, Liu SF.

Zhonghua Zhong Liu Za Zhi. 2006 Jul;28(7):536-8. Chinese.

PMID:
17147122
12.

Overexpression of hnRNPA2/B1 in bronchoscopic specimens: a potential early detection marker in lung cancer.

Katsimpoula S, Patrinou-Georgoula M, Makrilia N, Dimakou K, Guialis A, Orfanidou D, Syrigos KN.

Anticancer Res. 2009 Apr;29(4):1373-82.

13.

Diagnostic utility of VEGF mRNA and SP1 mRNA expression in bronchial cells of patients with lung cancer.

Cha N, Lv M, Zhao YJ, Yang D, Wang EH, Wu GP.

Respirology. 2014 May;19(4):544-8. doi: 10.1111/resp.12272. Epub 2014 Mar 24.

14.

Two microRNA panels to discriminate three subtypes of lung carcinoma in bronchial brushing specimens.

Huang W, Hu J, Yang DW, Fan XT, Jin Y, Hou YY, Wang JP, Yuan YF, Tan YS, Zhu XZ, Bai CX, Wu Y, Zhu HG, Lu SH.

Am J Respir Crit Care Med. 2012 Dec 1;186(11):1160-7. doi: 10.1164/rccm.201203-0534OC. Epub 2012 Oct 4.

PMID:
23043084
15.

Great potential of a panel of multiple hMTH1, SPD, ITGA11 and COL11A1 markers for diagnosis of patients with non-small cell lung cancer.

Chong IW, Chang MY, Chang HC, Yu YP, Sheu CC, Tsai JR, Hung JY, Chou SH, Tsai MS, Hwang JJ, Lin SR.

Oncol Rep. 2006 Nov;16(5):981-8.

PMID:
17016581
16.

Increased phospho-AKT (Ser(473)) expression in bronchial dysplasia: implications for lung cancer prevention studies.

Tsao AS, McDonnell T, Lam S, Putnam JB, Bekele N, Hong WK, Kurie JM.

Cancer Epidemiol Biomarkers Prev. 2003 Jul;12(7):660-4.

17.
18.

Application of ThinPrep bronchial brushing cytology in the early diagnosis of lung cancer: a retrospective study.

Liu C, Wen Z, Li Y, Peng L.

PLoS One. 2014 Apr 23;9(4):e90163. doi: 10.1371/journal.pone.0090163. eCollection 2014.

19.

Expression of IRAK1 in lung cancer tissues and its clinicopathological significance: a microarray study.

Zhang X, Dang Y, Li P, Rong M, Chen G.

Int J Clin Exp Pathol. 2014 Oct 15;7(11):8096-104. eCollection 2014.

20.

EGFR expression as an ancillary tool for diagnosing lung cancer in cytology specimens.

Wei EX, Anga AA, Martin SS, Jackson JG, Nordberg ML, Herrera GA, Turbat-Herrera EA.

Mod Pathol. 2007 Sep;20(9):905-13. Epub 2007 Jul 20.

Items per page

Supplemental Content

Write to the Help Desk